Using CBD Oil For Arthritis
The benefits of CBD for arthritis sufferers are not subject to much dispute. However, a closer examination of CBD and arthritis unfortunately reveals what happens within the medical world when such a scenario takes place. To date, only epilepsy has been the only condition where CBD oil has been an FDA-approved medicine. What this means for the average consumer is that CBD can only be legally purchased through a valid prescription from a physician or other licensed medical professional. Any other form of CBD available to consumers is considered a dietary supplement and therefore is not regulated by the FDA.
When CBD is taken by a person who suffers from epilepsy, it seems likely that there will be an immediate correlation between the two. Since CBD significantly inhibits inflammation, it makes perfect sense that patients suffering from arthritis would greatly benefit from the natural healing-healing power of this plant as opposed to prescription pain killers or anti-inflammatory medications. In addition, if patients with epilepsy use CBD oil for arthritis, it is entirely possible that their symptoms can subside completely over time, even without taking additional medication. This would be particularly true if the patient were able to continue with their natural arthritis treatment along with CBD.
While some argue that CBD should not be used in conjunction with prescription medication, those who suffer from arthritis strongly disagree. After all, it has long been known that CBD oils are not only all-natural but have also been shown to be highly effective in reducing pain without causing dangerous side effects. This speaks to the effectiveness of CBD when it comes to combating pain and inflammation, and it clearly shows why it should be considered as an integral part of the regimen of anyone who suffers from arthritis. Furthermore, the fact that CBD is a non-psychoactive substance makes it a particularly attractive option for anyone who suffers from arthritis. It presents no danger of dependency while offering patients real health benefits, including an overall reduction in joint pain. Some even report an increase in energy, leading to a more positive outlook on life!
Unfortunately, many people are still unfamiliar with the most recent scientific research on CBD and pain relief, which indicates that CBD may indeed be more effective than most prescription and over-the-counter pain killers when it comes to reducing pain and inflammation. For years, CBD has been touted as a potential “cure” for everything from stomach pain to arthritic joint pain. One recent study conducted at the University of California-Irvine showed that CBD may be able to significantly reduce pain and improve function in chronic muscle and joint pain sufferers. The study looked at the effect of CBD on a group of mice that had muscle and joint inflammation. The scientists found that half of the group was completely unresponsive to a variety of anti-inflammatory drugs. However, when the same group was given CBD before receiving the drugs, they exhibited significant improvement in muscle and joint pain and inflammation when compared to a placebo group that received the drugs but had no CBD.
Many of us believe that pharmaceutical drugs are the only way to effectively treat our joint problems, but researchers now believe that we may be able to find better solutions by utilizing oils such as CBD. One of the major problems with current anti-inflammatory treatments is that they can have some pretty serious side effects, such as nausea, vomiting, dizziness and even depression. In addition, pharmaceutical drugs often come with a list of dangerous side effects, such as memory loss, headaches, vomiting, bleeding and even death. The bottom line is that many patients simply do not want to take pharmaceuticals any longer and are instead turning to alternative therapies such as herbal supplements, which often work with fewer side effects and can be taken along with prescription medications.
In the UK, two clinical trials involving CBD were recently approved for use. One study, funded by the National Institute for Health, showed promising results for patients with mild to moderate epilepsy as well as those with severe epilepsy, as well as those with cognitive impairment and memory loss. The second study, funded by the National Institute for Medicines, was aimed at evaluating the safety and effectiveness in patients with moderate to severe pain due to osteoarthritis.